89 related articles for article (PubMed ID: 19933673)
1. Optimal timing of breast MRI examinations for premenopausal women who do not have a normal menstrual cycle.
Ellis RL
AJR Am J Roentgenol; 2009 Dec; 193(6):1738-40. PubMed ID: 19933673
[TBL] [Abstract][Full Text] [Related]
2. A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.
Pujol P; Daures JP; Brouillet JP; Chang S; Rouanet P; Bringer J; Grenier J; Maudelonde T
Cancer; 2001 May; 91(10):1854-61. PubMed ID: 11346866
[TBL] [Abstract][Full Text] [Related]
3. Breast MRI using a high-relaxivity contrast agent: an overview.
Carbonaro LA; Pediconi F; Verardi N; Trimboli RM; Calabrese M; Sardanelli F
AJR Am J Roentgenol; 2011 Apr; 196(4):942-55. PubMed ID: 21427349
[TBL] [Abstract][Full Text] [Related]
4. Background parenchymal enhancement on breast MRI: influence of menstrual cycle and breast composition.
Kang SS; Ko EY; Han BK; Shin JH; Hahn SY; Ko ES
J Magn Reson Imaging; 2014 Mar; 39(3):526-34. PubMed ID: 23633296
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women.
Wright H; Listinsky J; Rim A; Chellman-Jeffers M; Patrick R; Rybicki L; Kim J; Crowe J
Am J Surg; 2005 Oct; 190(4):572-5. PubMed ID: 16164923
[TBL] [Abstract][Full Text] [Related]
6. Menstrual timing of treatment for breast cancer.
Senie RT; Kinne DW
J Natl Cancer Inst Monogr; 1994; (16):85-90. PubMed ID: 7999475
[TBL] [Abstract][Full Text] [Related]
7. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
[TBL] [Abstract][Full Text] [Related]
8. Use of serum progesterone concentration for timing breast MRI examinations and avoiding false-negative findings.
Ganau S; SentÃs M; Tortajada L
AJR Am J Roentgenol; 2010 Jul; 195(1):W85; author reply W86. PubMed ID: 20566787
[No Abstract] [Full Text] [Related]
9. Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women.
Clendenen TV; Kim S; Moy L; Wan L; Rusinek H; Stanczyk FZ; Pike MC; Zeleniuch-Jacquotte A
Magn Reson Imaging; 2013 Jan; 31(1):1-9. PubMed ID: 22898693
[TBL] [Abstract][Full Text] [Related]
10. Survival of premenopausal women with breast carcinoma: effects of menstrual timing of surgery.
Harlap S; Zauber AG; Pollack DM; Tang J; Arena AE; Sternfels P; Borgen P; Norton L
Cancer; 1998 Jul; 83(1):76-88. PubMed ID: 9655296
[TBL] [Abstract][Full Text] [Related]
11. Timing of breast cancer surgery during the luteal menstrual phase may improve prognosis.
Lemon HM; Rodriguez-Sierra JF
Nebr Med J; 1996 Mar; 81(3):73-8. PubMed ID: 8907825
[TBL] [Abstract][Full Text] [Related]
12. Timing of breast cancer surgery during the luteal menstrual phase may improve prognosis.
Lemon HM; Rodriguez-Sierra JF
Nebr Med J; 1996 Apr; 81(4):110-5. PubMed ID: 8628449
[TBL] [Abstract][Full Text] [Related]
13. Should breast MRI be performed with adjustment for the phase in patients' menstrual cycle? Correlation between mammographic density, age, and background enhancement on breast MRI without adjusting for the phase in patients' menstrual cycle.
Uematsu T; Kasami M; Watanabe J
Eur J Radiol; 2012 Jul; 81(7):1539-42. PubMed ID: 21592704
[TBL] [Abstract][Full Text] [Related]
14. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
15. Lack of the relationship between menstrual status and timing of surgery in survival of premenopausal patients with breast cancer.
Tsuchiya A; Furukawa H; Kanno M; Kimijima I; Abe R
Fukushima J Med Sci; 1996 Dec; 42(1-2):11-6. PubMed ID: 9127965
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of gadobenate dimeglumine for contrast-enhanced MRI of the breast.
Hylton NM
AJR Am J Roentgenol; 2003 Sep; 181(3):677-8. PubMed ID: 12933458
[No Abstract] [Full Text] [Related]
17. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
Wang QJ; Wang Y; Xu X; Xiao H; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.
Pediconi F; Catalano C; Padula S; Roselli A; Dominelli V; Cagioli S; Kirchin MA; Pirovano G; Passariello R
AJR Am J Roentgenol; 2008 Nov; 191(5):1339-46. PubMed ID: 18941066
[TBL] [Abstract][Full Text] [Related]
19. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
Linda A; Zuiani C; Furlan A; Lorenzon M; Londero V; Girometti R; Bazzocchi M
AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
[TBL] [Abstract][Full Text] [Related]
20. Outcome of Screening MRI in Premenopausal Women as a Function of the Week of the Menstrual Cycle.
Lee CH; Bryce Y; Zheng J; Sung JS; Comstock CE; Moskowitz C; A Morris E
AJR Am J Roentgenol; 2020 May; 214(5):1175-1181. PubMed ID: 32160053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
